Business Description
Biogena Group Invest AG
ISIN : ATBIOGENA005
Share Class Description:
WBO:BIO: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIO.Austria IPO Date
2020-11-27Description
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 12.55 | |||||
| Beneish M-Score | -2.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -36.6 | |||||
| 3-Year EBITDA Growth Rate | -16.7 | |||||
| 3-Year EPS without NRI Growth Rate | -9.5 | |||||
| 3-Year Book Growth Rate | 24.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.38 | |||||
| 9-Day RSI | 20.44 | |||||
| 14-Day RSI | 28.78 | |||||
| 12-1 Month Momentum % | -18.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.78 | |||||
| Quick Ratio | 3.78 | |||||
| Cash Ratio | 0.06 | |||||
| Days Sales Outstanding | 43.98 | |||||
| Days Payable | 6022.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.6 | |||||
| Dividend Payout Ratio | 1.16 | |||||
| Forward Dividend Yield % | 1.6 | |||||
| 5-Year Yield-on-Cost % | 1.6 | |||||
| 3-Year Average Share Buyback Ratio | -26 | |||||
| Shareholder Yield % | 1.6 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.4 | |||||
| Operating Margin % | 1.81 | |||||
| Net Margin % | 103.61 | |||||
| ROE % | 2.02 | |||||
| ROA % | 1.96 | |||||
| ROIC % | 0.03 | |||||
| ROC (Joel Greenblatt) % | 58.67 | |||||
| ROCE % | 2.06 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 43.49 | |||||
| PE Ratio without NRI | 43.49 | |||||
| PS Ratio | 44.52 | |||||
| PB Ratio | 0.88 | |||||
| Price-to-Tangible-Book | 0.88 | |||||
| EV-to-EBIT | 42.26 | |||||
| EV-to-EBITDA | 42.26 | |||||
| EV-to-Revenue | 44.81 | |||||
| Price-to-Graham-Number | 1.3 | |||||
| Price-to-Net-Current-Asset-Value | 7.79 | |||||
| Earnings Yield (Greenblatt) % | 2.37 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers